Bio-Rad Laboratories Inc. (BIO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Bio-Rad Laboratories Inc.

    NYSE: BIO · Real-Time Price · USD
    295.08
    5.65 (1.95%)
    At close: Sep 05, 2025, 3:59 PM
    295.43
    0.12%
    After-hours: Sep 05, 2025, 06:04 PM EDT

    Bio-Rad Laboratories Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 488.1M 403.8M 434.21M 470.78M
    Short-Term Investments
    		 1.18B 1.2B 1.36B 399.13M
    Long-Term Investments
    		 4.84B 7.7B 8.83B 14.39B
    Other Long-Term Assets
    		 101.9M 94.9M 94.6M 104.19M
    Receivables
    		 452.5M 489M 494.64M 423.54M
    Inventory
    		 760M 780.5M 719.32M 572.24M
    Other Current Assets
    		 30.7M 31.7M 29.16M 15.65M
    Total Current Assets
    		 3.03B 3.05B 3.16B 1.99B
    Property-Plant & Equipment
    		 688.6M 723.7M 679.55M 716.44M
    Goodwill & Intangibles
    		 704.1M 734.1M 738.6M 601.2M
    Total Long-Term Assets
    		 6.33B 9.25B 10.34B 15.81B
    Total Assets
    		 9.36B 12.3B 13.5B 17.8B
    Account Payables
    		 122.3M 144.6M 135.04M 141.94M
    Deferred Revenue
    		 n/a n/a 52.21M 50.85M
    Short-Term Debt
    		 1.2M 500K 465K 489K
    Other Current Liabilities
    		 147.2M 161.6M 117.44M 127.94M
    Total Current Liabilities
    		 467.8M 522.8M 568.71M 680.94M
    Long-Term Debt
    		 1.2B 1.2B 1.2B 10.51M
    Other Long-Term Liabilities
    		 177.2M 195M 195.93M 182.19M
    Total Long-Term Liabilities
    		 2.33B 3.04B 3.32B 3.43B
    Total Liabilities
    		 2.79B 3.56B 3.89B 4.11B
    Total Debt
    		 1.37B 1.41B 1.39B 223.38M
    Common Stock
    		 n/a n/a 3K 3K
    Retained Earnings
    		 7.42B 9.26B 9.9B 13.53B
    Comprehensive Income
    		 -538.2M -336M -466.82M -175.55M
    Shareholders Equity
    		 6.57B 8.74B 9.62B 13.69B
    Total Investments
    		 6.02B 8.9B 10.19B 14.79B

    Add to Watchlist